The host response to mycobacterial infection is highly variable. A role for hostand bacterial factors in this variability is well established, although it is not knownwhether these factors act independently of each other or whether infectionoutcome results from a joint effect of host and pathogen. To address thisquestion, the present thesis concurrently examined the effect of geneticallycontrolled host and bacterial factors using a mouse model of infection. A panel ofrecombinant congenic (RC) mouse strains and their A/J and C57BL/6J inbredprogenitors were infected with virulent Mycobacterium tuberculosis or theattenuated M. bovis Bacille Calmette Guérin (BCG) Russia and Pasteur strains. Ajoint effect of host and pathogen on the course of my...
The variable outcome of Mycobacterium tuberculosis infection observed in natural populations is diff...
AbstractTuberculosis continues to be the main cause of death from a single infectious agent in devel...
<div><p>Molecular epidemiological assessments, drug treatment optimization, and development of immun...
The host response to mycobacterial infection depends on host and pathogen genetic factors. Recent st...
The host response to mycobacterial infection depends on host and pathogen genetic factors. Recent st...
The outcome of an encounter with Mycobacterium tuberculosis (Mtb) depends on the pathogen's ability ...
La tuberculose, causée par Mycobacterium tuberculosis, connaît actuellement une résurgence inquiétan...
The outcome of an encounter with Mycobacterium tuberculosis (Mtb) depends on the pathogen’s ability ...
In the mouse, innate resistance or susceptibility to infection with numerous mycobacteria is control...
Host genetics plays an important role in determining the outcome of Mycobacterium tuberculosis infec...
There is substantial epidemiological evidence that host genetic factors in part determine susceptibi...
Mycobacterium tuberculosis (Mtb) is the etiological agent of the disease tuberculosis (TB), and is t...
ABSTRACT The outcome of Mycobacterium tuberculosis infection and the immunological response to the b...
Genetic control of susceptibility to tuberculosis in resistant C57BL/6 (B6) and susceptible DBA/2 (D...
Resumen del póster presentado al 41st Annual Congress of the European Society of Mycobacteriology (E...
The variable outcome of Mycobacterium tuberculosis infection observed in natural populations is diff...
AbstractTuberculosis continues to be the main cause of death from a single infectious agent in devel...
<div><p>Molecular epidemiological assessments, drug treatment optimization, and development of immun...
The host response to mycobacterial infection depends on host and pathogen genetic factors. Recent st...
The host response to mycobacterial infection depends on host and pathogen genetic factors. Recent st...
The outcome of an encounter with Mycobacterium tuberculosis (Mtb) depends on the pathogen's ability ...
La tuberculose, causée par Mycobacterium tuberculosis, connaît actuellement une résurgence inquiétan...
The outcome of an encounter with Mycobacterium tuberculosis (Mtb) depends on the pathogen’s ability ...
In the mouse, innate resistance or susceptibility to infection with numerous mycobacteria is control...
Host genetics plays an important role in determining the outcome of Mycobacterium tuberculosis infec...
There is substantial epidemiological evidence that host genetic factors in part determine susceptibi...
Mycobacterium tuberculosis (Mtb) is the etiological agent of the disease tuberculosis (TB), and is t...
ABSTRACT The outcome of Mycobacterium tuberculosis infection and the immunological response to the b...
Genetic control of susceptibility to tuberculosis in resistant C57BL/6 (B6) and susceptible DBA/2 (D...
Resumen del póster presentado al 41st Annual Congress of the European Society of Mycobacteriology (E...
The variable outcome of Mycobacterium tuberculosis infection observed in natural populations is diff...
AbstractTuberculosis continues to be the main cause of death from a single infectious agent in devel...
<div><p>Molecular epidemiological assessments, drug treatment optimization, and development of immun...